Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Mar;31(3):289-300.
doi: 10.1007/s00296-010-1586-z. Epub 2010 Jul 30.

Current, new and future treatments of osteoporosis

Affiliations
Review

Current, new and future treatments of osteoporosis

Pooneh Salari Sharif et al. Rheumatol Int. 2011 Mar.

Abstract

Osteoporosis as a common chronic disease is challenging human health. Although different therapeutic options are routinely used for prevention/treatment of osteoporosis, their side effects and benefits are under question. Increasing our knowledge about signaling pathways in bone and osteocytes as well as osteoblasts and osteoclasts will help us in designing new therapeutic modalities for osteoporosis. In the present study, all new therapeutic measures of osteoporosis have been reviewed. For this purpose, search engines like Pubmed, Web of Science, Scopus, Google Scholar were searched and all relevant articles were found. The study was limited to the year 1998-2010. Bisphosphonates are the cornerstone of osteoporosis treatment, but there are not enough relevant studies that investigated their equivalencies in comparison with each other or the other medications. Therefore, medication selection is empirical and subjective. Furthermore, no eminent study has compared certain combinations. There are new hopes for treatment of osteoporosis, which are more specific with less harm. Our results show that new and emerging therapies are more potent and target specified which more individualize osteoporosis treatment; however, more investigations on their safety and efficacy in comparison with current medications are highly recommended.

PubMed Disclaimer

References

    1. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005326 - PubMed
    1. Curr Osteoporos Rep. 2008 Dec;6(4):142-8 - PubMed
    1. N Engl J Med. 2003 Jul 31;349(5):457-63 - PubMed
    1. J Bone Miner Res. 2006 Apr;21(4):536-42 - PubMed
    1. J Biol Chem. 2004 Aug 27;279(35):36293-8 - PubMed

MeSH terms

Substances

LinkOut - more resources